Any Solid Tumor or Lymphoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Any Solid Tumor or Lymphoma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1/2

NCT03556228

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

This is a multicenter, open-label, Phase 1/2 study of orally administered VMD-928 monotherapy and in combination with pembrolizumab in adult subjects with advan…

United States242 participantsStarted 2018-06-08

Treatment: VMD-928 100 mg Tablet, VMD-928 Tablet and Pembrolizumab (200 mg)

All recent trials (3 shown)

CompletedPhase 1

NCT01460134

A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

This is a study of CDX-1127, a therapy that targets the immune system and may act to promote anti-cancer effects. The study enrolls patients with hematologic ca…

United States90 participantsStarted 2011-10

Treatment: CDX-1127, CDX-1127

CompletedPhase 1

NCT00698243

Study of Oral OSI-027 in Patients With Advanced Solid Tumors or Lymphoma

The primary objective of this study is to determine the maximum tolerated dose (MTD) and to establish the recommended phase 2 dose of oral OSI-027 when administ…

United States, Belgium, United Kingdom128 participantsStarted 2008-06

Treatment: OSI-027